Search

Author/Creator Oughton, Jamie B.

1. CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer. (November 2020)

Authors:
Walls, Gerard M.; Oughton, Jamie B.; Chalmers, Anthony J.; Brown, Sarah; Collinson, Fiona; Forster, Martin D.; Franks, Kevin N.; Gilbert, Alexandra; Hanna, Gerard G.; Hannaway, Nicola; Harrow, Stephen; Haswell, Tom; Hiley, Crispin T.; Hinsley, Samantha; Krebs, Matthew; Murden, Geraldine; Phillip,...
Journal:
Clinical and translational radiation oncology
Issue:
Volume 25(2020)
Page Start:
61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. COSMIC, chemotherapy plus ofatumumab at standard or mega‐dose in chronic lymphocytic leukaemia, a phase II randomised study. (24th May 2021)

Authors:
Allsup, David; Howard, Dena; Emmerson, Jake; Hockaday, Anna; Rawstron, Andy; Oughton, Jamie B.; Bloor, Adrian; Phillips, David; Nathwani, Amit; Paneesha, Shankara; Turner, Deborah; Munir, Talha; Hillmen, Peter
Journal:
British journal of haematology
Issue:
Volume 194:Number 3(2021)
Page Start:
646
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Obinutuzumab as consolidation after chemo‐immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial. (26th August 2022)

Authors:
Munir, Talha; Emmerson, Jake; Hockaday, Anna; Oughton, Jamie B.; Howard, Dena; Phillips, David; Neilson, Jeff; Pemberton, Nicholas; Paneesha, Shankara; Kennedy, Ben; Rawstron, Andy; Hillmen, Peter
Journal:
British journal of haematology
Issue:
Volume 199:Number 5(2022)
Page Start:
707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗